Alpha DNA Investment Management’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,808
Closed -$119K 570
2021
Q1
$119K Hold
1,808
0.14% 116
2020
Q4
$115K Buy
+1,808
New +$116K 0.12% 130

Other funds holding SRE

Alpha DNA Investment Management's SRE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Sempra (SRE) in Q2 2021, closing a stake of 1,808 shares — an estimated $119K sold.

Alpha DNA Investment Management first reported a position in SRE in Q4 2020 and held it in 2 quarters. The position peaked at $119K in Q1 2021. 816 funds tracked by Wall St. Rank hold SRE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Sempra position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,808 Sempra shares in Q2 2021, an estimated $119K.
  • Alpha DNA Investment Management first reported a position in Sempra in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Sempra position peaked at $119K in Q1 2021.
  • 816 funds tracked by Wall St. Rank held Sempra as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.